Table of Contents
1 Industry Outlook 9
1.1 Industry Overview 9
1.2 Industry Trends 9
1.3 Total Addressable Market 10
2 Report Outline 11
2.1 Report Scope 11
2.2 Report Summary 11
2.3 Research Methodology 12
2.4 Report Assumptions 13
3 Market Snapshot 13
3.1 Market Definition - Infoholic Research 14
3.2 Segmented Addressable Market 14
3.2.1 Components of Transdermal Patch 15
3.2.2 Advantages of Transdermal Drug Delivery 15
3.2.3 Disadvantages of Transdermal Drug Delivery 15
3.2.4 Diseases Treated by Transdermal Drug Delivery Systems 15
3.2.5 Trends in Transdermal Drug Delivery Market 16
3.3 Related Markets 17
3.3.1 Active Pharmaceutical Ingredients 17
3.3.2 Pulmonary Drug Delivery Systems 18
3.3.3 Injectable Drug Delivery Systems 18
4 Market Outlook 19
4.1 Overview 19
4.2 Market Segmentation 20
4.3 Porter 5(Five) Forces 20
4.4 PEST Analysis 21
5 Market Characteristics 22
5.1 Market Dynamics 22
5.1.1 Drivers 23
5.1.1.1 Increasing aging population 23
5.1.1.2 Growing patient base of chronic diseases 23
5.1.1.3 Increasing demand for transdermal drug delivery 24
5.1.2 Opportunities 24
5.1.2.1 Increased healthcare spending 24
5.1.2.2 Increasing clinical trials and product launches 24
5.1.3 Restraints 25
5.1.3.1 Side effects of transdermal drug delivery 25
5.1.3.2 Delivery limitation through skin 25
5.1.3.3 Availability of alternative drug delivery systems 26
5.2 DRO - Impact Analysis 26
5.3 Key Stakeholders 26
6 Types: Market Size and Analysis 27
6.1 Overview 27
6.2 Patches 28
6.3 Gels 29
7 Technology: Market Size and Analysis 29
7.1 Overview 30
7.2 Passive 30
7.3 Active 30
7.3.1 Thermal Technology 31
7.3.2 Ultrasound Devices 31
7.3.3 Electrical Techniques 31
7.3.4 Mechanical Methods 32
7.3.5 Velocity-based Devices 33
8 Drug Types: Market Size and Analysis 33
8.1 Overview 33
8.2 Fentanyl 33
8.3 Nicotine Transdermal Patch 34
8.4 Nitroglycerin Transdermal Patch 34
8.5 Clonidine Transdermal Patch 34
8.6 Estradiol 35
8.7 Testosterone 35
8.8 Others 35
9 Regions: Market Size and Analysis 35
9.1 Overview 35
9.2 North America 36
9.2.1 Overview 36
9.3 Europe 38
9.3.1 Overview 38
9.4 Asia Pacific 39
9.4.1 Overview 39
9.5 Rest of the World 40
9.5.1 Overview 40
10 Competitive Landscape 41
11 Vendor Profiles 44
11.1 Novartis AG 44
11.1.1 Overview 44
11.1.2 Business Units 47
11.1.3 Geographic Revenue 48
11.1.4 Business Focus 49
11.1.5 SWOT Analysis 49
11.1.6 Business Strategies 50
11.2 3M 51
11.2.1 Overview 51
11.2.2 Business Units 52
11.2.3 Geographic Revenue 53
11.2.4 Business Focus 54
11.2.5 SWOT Analysis 55
11.2.6 Business Strategies 55
11.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) 55
11.3.1 Overview 55
11.3.2 Business Units 59
11.3.3 Geographic Revenue 60
11.3.4 Business Focus 61
11.3.5 SWOT Analysis 62
11.3.6 Business Strategies 63
11.4 GlaxoSmithKline plc 63
11.4.1 Overview 63
11.4.2 Business Units 65
11.4.3 Geographic Revenue 66
11.4.4 Business Focus 67
11.4.5 SWOT Analysis 67
11.4.6 Business Strategies 68
11.5 Boehringer Ingelheim GmbH 68
11.5.1 Overview 68
11.5.2 Business Units 70
11.5.3 Geographic Revenue 71
11.5.4 Business Focus 72
11.5.5 SWOT Analysis 72
11.5.6 Business Strategies 73
11.6 Mylan N.V. 73
11.6.1 Overview 73
11.6.2 Business Units 75
11.6.3 Geographic Revenue 77
11.6.4 Business Focus 77
11.6.5 SWOT Analysis 77
11.6.6 Business Strategies 78
12 Companies to Watch For 78
12.1 Echo Therapeutics' Inc. 78
12.1.1 Overview 78
12.1.2 Highlights 79
12.2 Noven Pharmaceuticals' Inc. 79
12.2.1 Overview 79
12.2.2 Highlights 80
12.3 Transdermal Corp. 80
12.3.1 Overview 80
12.4 Bayer AG 81
12.4.1 Overview 81
12.5 Actavis' Inc. 82
12.5.1 Overview 82
12.6 Corium International' Inc. 82
12.6.1 Overview 82
Annexure 84
Abbreviations 84

?